Pediatrician Office Drug Prevention

描述（由申请人提供）：拟议的第一阶段SBIR项目将展示开发可通过儿科医生办公室主持的药物预防模块的可行性。干预措施将帮助青少年（11-15岁）的父母预防入门毒品的开始，包括酒精、烟草、大麻和吸入剂。该项目将通过CHADIS（儿科医生办公室可使用的订阅门户网站）主持。该模块将包括：(1)对父母及其青少年子女进行访问前筛查调查；(2)数据驱动的风险诊断；(3)以临床医生为中心，指导家长选择适合风险的教育材料；(4)父母教育成分。在第一阶段，将开发诊断算法的原型版本和原型家长教育材料并进行试点测试。该计划将重点关注11个与之前评估过的预防吸毒的育儿计划相同的要素。这包括帮助父母对不当行为进行适当的管教，为可接受的行为建立界限，为不可接受的行为定义限制，关注并加强积极的行为，有效地传达亲社会的规范、价值观和期望，提供监督，监视朋友、活动和行踪，表现出温暖，给予社会支持，建立情感依恋，分享美好的时光，并成功地解决冲突。第一期项目将重点完成五项任务。(1)我们将进行会诊前评估。一系列调查将评估青少年的风险状况，并了解父母的育儿长处和短处。这项调查将不考虑那些需要对药物使用障碍进行临床治疗的青少年。在那些未被排除的人中，调查将评估青少年使用入门毒品风险的有效标志。(2)我们将使用现有数据集开发一种精算风险算法，以使用精算方法估计青少年个体使用每种门户药物的风险。这些分析的目的是准确估计未来30天入门药物使用的概率。(3)完成干预原型开发。我们将制定一系列新的关键活动，处理以家庭为基础的毒品预防的11个共同要素中的每一个。这将有助于父母改善与预防青少年吸毒有关的养育态度和技能。(4)我们将制定一个医生办公室协议的原型。这将使儿科医生和辅助人员

DESCRIPTION (provided by applicant): The proposed Phase I SBIR project will demonstrate the feasibility of developing a drug prevention module that can be hosted through pediatrician offices. The intervention will assist parents of adolescents (ages 11-15) prevent the onset of gateway drugs, including alcohol, tobacco, marijuana, and inhalants. The program will be hosted via CHADIS, a subscription web portal available to pediatrician offices. This module will include: (1) pre-visit screening surveys for both parents and their adolescent children; (2) data-driven risk diagnoses; (3) clinician-focused instructions for selecting risk-appropriate educationa materials for parents; and (4) parental education components. During Phase I, a prototype version of the diagnosis algorithm and prototypical parent education materials will be developed and pilot tested. The program will focus on 11 elements common to previously evaluated parenting programs for the prevention of drug use. These include helping parents provide appropriate discipline for misbehavior, establish boundaries for acceptable behavior and define restrictions for unacceptable behavior, attend to and reinforce positive behavior, effectively communicate prosocial norms, values and expectations, provide supervision, monitor friends, activities, and whereabouts, show warmth, give social support, build emotional attachments, share quality time together, and successfully resolve conflicts. The Phase I project will focus on completing five tasks. (1) We will develop a pre-visit assessment. A set of surveys will assess the risk-status of adolescents and understand the parenting strengths and weakness of parents. The survey will exclude from consideration those youth who have the need for clinical treatment for substance use disorders. Among those not excluded, the survey will then assess validated markers of a teen's risk for using gateway drugs. (2) We will use existing datasets to develop an actuarial risk algorithm to estimate an individual adolescent's risk for using each gateway drug using actuarial methods. The objective of these analyses is to accurately estimate the probability of future 30-day gateway drug use. (3) We will complete prototype intervention development. We will develop a new series of key activities that address each of the 11 common elements of family-based drug prevention. These will help parents improve their parenting attitudes and skills related to preventing drug use among their adolescents. (4) We will develop a prototype physician office protocol. This will allow pediatricians and support staff to be intermediaries in the delivery of the parenting intervention. (5) We will complete a feasibility study. The objective of this study will be to demonstrate that all elements function as designed, are capable of fulfilling their intended roles and are deemed acceptable. Participants will be 20 families whose adolescents are cared for by a pediatric practice. Adolescents and parents will be screened. Actuarial estimates of future drug use will be provided to the pediatric office. Pediatricians will prescribe the prevention program to parents who will collectively test al instructional components. Post intervention assessments gathered from parents, adolescents, physicians, and other staff will assess intervention functioning, usability, and acceptability.